Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7089263

O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.[Al+3].[O-]c1cccc(F)c1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.44
PTPN1 P18031 2/20 0.38
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
KCNH2 Q12809 6/20 0.36
ACHE P22303 5/20 0.36
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
ABCC9 O60706 1/20 0.33
ABCC8 Q09428 1/20 0.33
KCNJ11 Q14654 1/20 0.33
KCNJ8 Q15842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL7089262 0.87 PTPN1 (0.47) GPR3PTPN1CA12CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL7090349 0.80 GPR3 (0.41) GPR3PTPN1ACHECES2CES1
Trifluoromethanesulfonic Acid SCHEMBL7089027 0.80 GPR3 (0.43) GPR3PTPN1KCNH2ACHE
Trifluoromethanesulfonic Acid SCHEMBL6560666 0.78 GPR3 (0.57) GPR3PTPN1CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL7089713 0.77 ACHE (0.42) GPR3PTPN1KCNH2ACHE
Lithium Ion SCHEMBL31616118 0.77
SCHEMBL10487139 0.77
1-Hydroxy-3-Methoxybenzene SCHEMBL7085847 0.76 KCNH2 (0.49) GPR3CA12CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL7086264 0.76 GPR3 (0.40) GPR3CA12CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL7092453 0.76 L3MBTL1 (0.41) GPR3KCNH2ACHEPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624321-B2 Metathesis ring-opening polymerization of cyclic ethers in the presence of catalysts such as aluminum bis(trifluoromethane-sulfonate) phenolate BAYER AKTIENGESELLSCHAFT (DE) 2003-09-23 US disclosed
US-20030097026-A1 Process for the preparation of polyether polyols DENNINGER UWE (DE) 2003-05-22 US disclosed
US-6492565-B2 USING ALKYLENE OXIDE IN PRESENCE OF LEWIS ACID CATALYST BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 US disclosed
US-20010053866-A1 Process for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2001-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097026-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 GPR3 3548/4885PTPN1 3839/4885CA12 313/4885
US-20010053866-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 GPR3 3548/4885PTPN1 3839/4885CA12 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.